Artigo de periodico

Antimicrobial therapy in severe septic ICU major burn patients to combat bacterial resistance by pharmacokinetic-pharmacodymamics of vancomycin, meropenem, and piperacillin, cultures, and inflammatory biomarkers (2024)

• Authors:
  • Silva Junior, Elson Mendes da
  • Silva Júnior, João Manoel da
  • Camargo, Thais Vieira de
  • Santos, Mauro Jorge
  • Abad, Aline Sandré Gomides
  • Ferreira, Gabriela Aparecida
  • Oliveira, Thiago Câmara de
  • Santos, Maria Severina dos
  • Duarte, Nilo José Coelho
  • Romano, Paschoalina
  • Ebner, Persio Almeida Rezende
  • Gómez, David de Souza
  • Santos, Silvia Regina Cavani Jorge
• USP affiliated authors: SILVA JUNIOR, JOÃO MANOEL DA - FM ; SANTOS, SILVIA REGINA CAVANI JORGE - FCF ; SILVA JÚNIOR, ELSON MENDES DA - FM ; DUARTE, NILO JOSE COELHO - FM
• Unidades: FM; FCF
• DOI: 10.15406/ppij.2024.12.00426
• Subjects: INFECÇÃO HOSPITALAR; FARMACODINÂMICA; FARMACOCINÉTICA; BIOMARCADORES
• Language: Inglês
• Imprenta:
  • Publisher place: Oklahoma
  • Date published: 2024
• Source:
  • Título: Pharmacy and Pharmacology International Journal
  • ISSN: 2379-6367
  • Volume/Número/Paginação/Ano: v. 12, N. 1, p. 14-22, 2024

Informações sobre o DOI: 10.15406/ppij.2024.12.00426 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: hybrid
• Licença: cc-by-nc

---

Download do texto completo

Tipo	Nome	Link
	3224829.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SILVA JUNIOR, Elson Mendes da et al. Antimicrobial therapy in severe septic ICU major burn patients to combat bacterial resistance by pharmacokinetic-pharmacodymamics of vancomycin, meropenem, and piperacillin, cultures, and inflammatory biomarkers. Pharmacy and Pharmacology International Journal, v. 12, p. 14-22, 2024Tradução . . Disponível em: https://dx.doi.org/10.15406/ppij.2024.12.00426. Acesso em: 02 jan. 2026.

• APA

  Silva Junior, E. M. da, Silva Júnior, J. M. da, Camargo, T. V. de, Santos, M. J., Abad, A. S. G., Ferreira, G. A., et al. (2024). Antimicrobial therapy in severe septic ICU major burn patients to combat bacterial resistance by pharmacokinetic-pharmacodymamics of vancomycin, meropenem, and piperacillin, cultures, and inflammatory biomarkers. Pharmacy and Pharmacology International Journal, 12, 14-22. doi:10.15406/ppij.2024.12.00426

• NLM

  Silva Junior EM da, Silva Júnior JM da, Camargo TV de, Santos MJ, Abad ASG, Ferreira GA, Oliveira TC de, Santos MS dos, Duarte NJC, Romano P, Ebner PAR, Gómez D de S, Santos SRCJ. Antimicrobial therapy in severe septic ICU major burn patients to combat bacterial resistance by pharmacokinetic-pharmacodymamics of vancomycin, meropenem, and piperacillin, cultures, and inflammatory biomarkers [Internet]. Pharmacy and Pharmacology International Journal. 2024 ; 12 14-22.[citado 2026 jan. 02 ] Available from: https://dx.doi.org/10.15406/ppij.2024.12.00426

• Vancouver

  Silva Junior EM da, Silva Júnior JM da, Camargo TV de, Santos MJ, Abad ASG, Ferreira GA, Oliveira TC de, Santos MS dos, Duarte NJC, Romano P, Ebner PAR, Gómez D de S, Santos SRCJ. Antimicrobial therapy in severe septic ICU major burn patients to combat bacterial resistance by pharmacokinetic-pharmacodymamics of vancomycin, meropenem, and piperacillin, cultures, and inflammatory biomarkers [Internet]. Pharmacy and Pharmacology International Journal. 2024 ; 12 14-22.[citado 2026 jan. 02 ] Available from: https://dx.doi.org/10.15406/ppij.2024.12.00426

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Biomarkers of septic shock to predict hospital mortality in major burns undergoing antimicrobial therapy during the systemic inflammatory response syndrome
• Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains
• Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance
• Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock
• The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus
• Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients
• Optimizing piperacillin dosing in pediatric liver transplant recipients: a case series
• Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns
• Método UHPLC-MS/MS para determinação da hidroxicloroquina e seus principais metabólitos em fluído oral e sangue total para monitorização terapêutica de drogas
• Caracterização da resposta inflamatória no paciente com infecção por HIV/aids e sepse